NCAM1 in BMD/DMD patients was not significantly different to controls, while in GNE myopathy there was a small increase compared to controls, but still significantly lower than in CMT patients (P = 0.032). This evidence concerns the gene NCAM1 and Duchenne muscular dystrophy.